| SS-Chr 3BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
8 |
|
0.53 |
IU/g |
0.08 |
0.23 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47462 |
461 |
| SS-Chr 3BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
8 |
|
14.3 |
IU/g |
1.82 |
5.14 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
48880 |
461 |
| SS-Chr 3BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
8 |
|
5.33 |
ml/min/g |
0.36 |
1.03 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
44773 |
461 |
| SS-Chr 3BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
8 |
|
4.33 |
ml/min/g |
0.46 |
1.3 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46262 |
461 |
| SS-Chr 3BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
8 |
|
0.87 |
IU/g |
0.07 |
0.21 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47325 |
461 |
| SS-Chr 3BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
|
8.48 |
ml/min/g |
0.81 |
2.56 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46930 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
47.3 |
% |
2.58 |
7.3 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46121 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
52.46 |
% |
3.95 |
11.17 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46126 |
461 |
| SS-Chr 3BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
8 |
|
5.29 |
ml/min/g |
0.76 |
2.15 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46257 |
461 |
| SS-Chr 3BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
10 |
|
0.44 |
IU/g |
0.08 |
0.27 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47331 |
461 |
| SS-Chr 3BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
7 |
|
16.25 |
IU/g |
2.42 |
6.41 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
48874 |
461 |
| SS-Chr 3BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
8 |
|
10.41 |
ml/min/g |
1.05 |
2.96 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46708 |
461 |
| SS-Chr 3BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
|
9.12 |
ml/min/g |
0.68 |
2.15 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46713 |
461 |
| SS-Chr 3BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
8 |
|
18.62 |
IU/g |
3.31 |
9.36 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
45978 |
461 |
| SS-Chr 3BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
10 |
|
15.78 |
IU/g |
1.02 |
3.22 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
45983 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
55.22 |
% |
6.66 |
18.84 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47132 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
48.99 |
% |
3.5 |
11.07 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47137 |
461 |
| SS-Chr 3BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
10 |
|
0.39 |
IU/g |
0.03 |
0.11 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47467 |
461 |
| SS-Chr 3BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
8 |
|
11.06 |
ml/min/g |
1.35 |
3.81 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46925 |
461 |
| SS-Chr 3BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
|
4.3 |
ml/min/g |
0.16 |
0.5 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
44778 |
461 |